• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)吸烟者、非COPD吸烟者及非吸烟者炎症细胞中磷酸二酯酶4(PDE4)环磷酸腺苷(cAMP)磷酸二酯酶亚型的差异表达

Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers.

作者信息

Barber Rachael, Baillie George S, Bergmann Reinhard, Shepherd Malcolm C, Sepper Ruth, Houslay Miles D, Heeke Gino Van

机构信息

Respiratory Disease Area, Novartis Horsham Research Center, Wimblehurst Road, Horsham RH12 5AB, United Kingdom.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L332-43. doi: 10.1152/ajplung.00384.2003. Epub 2004 Mar 26.

DOI:10.1152/ajplung.00384.2003
PMID:15047569
Abstract

The expression profile of a panel of 15 cAMP phosphodiesterase isoforms was determined for inflammatory cell types of relevance to chronic obstructive pulmonary disease (COPD). In particular, the expression profiles for bronchoalveolar macrophages, peripheral blood monocytes, T lymphocytes, and neutrophils from smokers with and without COPD were compared. The phosphodiesterase expression profile was also analyzed for peripheral blood monocytes, T lymphocytes, and neutrophils from nonsmokers and compared with smokers. Qualitative RT-PCR identified transcripts for PDE4A10, PDE4A7, PDE4B1, PDE4B2, PDE4D1, and PDE4D2 isoforms as well as transcripts for both PDE3B and PDE7A in T cells, monocytes, and macrophages in all subjects. Transcripts for PDE4B3 and PDE4D4 were not observed in any of the cell types investigated. PDE4C was detected in all cells analyzed except for T cells. The long PDE4A4, PDE4D3, and PDE4D5 isoforms exhibited cell type-specific expression patterns. Semiquantitative and real-time quantitative RT-PCR were used to analyze differential expression between disease states and between cell types. PDE4A4 was found significantly upregulated in lung macrophages from smokers with COPD when compared with control smokers. Furthermore, PDE4A4 as well as PDE4B2 transcripts were detected in higher amounts in peripheral blood monocytes of smokers when compared with nonsmokers. Finally, PDE4D5 and PDE4C were differentially regulated in lung macrophages when compared with monocytes of the same subjects, irrespective of the disease state. The data obtained suggest that PDE4A4 may be relevant as a macrophage-specific anti-inflammatory target for COPD.

摘要

测定了与慢性阻塞性肺疾病(COPD)相关的一组15种环磷酸腺苷磷酸二酯酶同工型在炎症细胞类型中的表达谱。特别比较了患有和未患有COPD的吸烟者的支气管肺泡巨噬细胞、外周血单核细胞、T淋巴细胞和中性粒细胞的表达谱。还分析了非吸烟者外周血单核细胞、T淋巴细胞和中性粒细胞的磷酸二酯酶表达谱,并与吸烟者进行了比较。定性逆转录聚合酶链反应(RT-PCR)鉴定出所有受试者的T细胞、单核细胞和巨噬细胞中PDE4A10、PDE4A7、PDE4B1、PDE4B2、PDE4D1和PDE4D2同工型的转录本以及PDE3B和PDE7A的转录本。在所研究的任何细胞类型中均未观察到PDE4B3和PDE4D4的转录本。除T细胞外,在所有分析的细胞中均检测到PDE4C。长链PDE4A4、PDE4D3和PDE4D5同工型表现出细胞类型特异性的表达模式。使用半定量和实时定量RT-PCR分析疾病状态之间以及细胞类型之间的差异表达。与对照吸烟者相比,发现患有COPD的吸烟者肺巨噬细胞中PDE4A4显著上调。此外,与非吸烟者相比,吸烟者外周血单核细胞中检测到的PDE4A4以及PDE4B2转录本含量更高。最后,与同一受试者的单核细胞相比,无论疾病状态如何,肺巨噬细胞中PDE4D5和PDE4C的表达受到不同调节。所获得的数据表明,PDE4A4可能作为COPD巨噬细胞特异性抗炎靶点具有相关性。

相似文献

1
Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers.慢性阻塞性肺疾病(COPD)吸烟者、非COPD吸烟者及非吸烟者炎症细胞中磷酸二酯酶4(PDE4)环磷酸腺苷(cAMP)磷酸二酯酶亚型的差异表达
Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L332-43. doi: 10.1152/ajplung.00384.2003. Epub 2004 Mar 26.
2
Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells.人U937细胞单核细胞-巨噬细胞分化过程中PDE4环磷酸腺苷磷酸二酯酶亚型谱的重塑。
Br J Pharmacol. 2004 May;142(2):339-51. doi: 10.1038/sj.bjp.0705770. Epub 2004 Apr 5.
3
Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.7-氧代前列环素预处理大鼠心脏中磷酸二酯酶1和磷酸二酯酶4环核苷酸磷酸二酯酶亚型的表达改变
J Mol Cell Cardiol. 1997 Nov;29(11):3135-46. doi: 10.1006/jmcc.1997.0544.
4
Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.原代皮层神经元中cAMP信号对4B型和4D型cAMP特异性磷酸二酯酶(PDE4)剪接变体的调控
J Neurochem. 2002 May;81(4):745-57. doi: 10.1046/j.1471-4159.2002.00878.x.
5
In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.在静止的COS1细胞中,一种显性负性方法表明,特定的、锚定的磷酸二酯酶4(PDE4)环磷酸腺苷(cAMP)磷酸二酯酶同工型通过基础cAMP生成,控制位于中心体区域的A激酶锚定蛋白(AKAP) tethered的II型蛋白激酶A的激活。
Cell Signal. 2005 Sep;17(9):1158-73. doi: 10.1016/j.cellsig.2005.04.003.
6
Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils.磷酸二酯酶4B2是主要的磷酸二酯酶种类,并且在人类单核细胞和嗜中性粒细胞中经历基因表达的差异调节。
Mol Pharmacol. 1999 Jul;56(1):170-4. doi: 10.1124/mol.56.1.170.
7
Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.用腺苷酸环化酶激活剂福斯高林刺激人Jurkat T细胞,通过上调磷酸二酯酶3(PDE3)、诱导磷酸二酯酶4D1(PDE4D1)和磷酸二酯酶4D2(PDE4D2)剪接变体以及下调一种新型磷酸二酯酶4A(PDE4A)剪接变体,引发环磷酸腺苷(cAMP)磷酸二酯酶(PDE)表达的重大变化。
Biochem J. 1997 Jan 1;321 ( Pt 1)(Pt 1):165-75. doi: 10.1042/bj3210165.
8
Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.咯利普兰占据磷酸二酯酶4A4(PDE4A4)环磷酸腺苷磷酸二酯酶的催化位点,通过一个不依赖环磷酸腺苷的过程触发这种特定亚型在活细胞中的动态重新分布。
Cell Signal. 2003 Oct;15(10):955-71. doi: 10.1016/s0898-6568(03)00092-5.
9
Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.环磷酸腺苷磷酸二酯酶PDE4D亚型的表达及未成熟大鼠支持细胞中促卵泡激素刺激的PDE4活性的年龄相关变化。
Biol Reprod. 2007 May;76(5):794-803. doi: 10.1095/biolreprod.106.055343. Epub 2007 Jan 10.
10
Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells.
Am J Physiol Lung Cell Mol Physiol. 2003 Feb;284(2):L279-89. doi: 10.1152/ajplung.00170.2002. Epub 2002 Oct 4.

引用本文的文献

1
Advancing Obstructive Airway Disease Treatment: Dual PDE3/4 Inhibition as a Therapeutic Strategy.推进阻塞性气道疾病治疗:双重磷酸二酯酶3/4抑制作为一种治疗策略。
Cells. 2025 Apr 30;14(9):659. doi: 10.3390/cells14090659.
2
Phosphodiesterase Inhibition as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease: Where We Have Been and What Lies Ahead.磷酸二酯酶抑制作为慢性阻塞性肺疾病的一种治疗策略:我们的历程与未来方向
Chronic Obstr Pulm Dis. 2025 Jan 29;12(1):82-92. doi: 10.15326/jcopdf.2024.0559.
3
Phosphodiesterase 4 is overexpressed in keloid epidermal scars and its inhibition reduces keratinocyte fibrotic alterations.
磷酸二酯酶 4 在瘢痕疙瘩表皮瘢痕中过度表达,其抑制可减少角质形成细胞的纤维化改变。
Mol Med. 2024 Sep 2;30(1):134. doi: 10.1186/s10020-024-00906-8.
4
Potential of phosphodiesterase 4B inhibitors in the treatment of interstitial lung disease associated with autoimmune diseases.磷酸二酯酶4B抑制剂在治疗自身免疫性疾病相关间质性肺疾病中的潜力。
Clin Exp Rheumatol. 2025 Jan;43(1):119-125. doi: 10.55563/clinexprheumatol/yg6rck. Epub 2024 Aug 20.
5
Therapeutic Targets and Precision Medicine in COPD: Inflammation, Ion Channels, Both, or Neither?COPD 的治疗靶点和精准医学:炎症、离子通道,还是两者兼有?
Int J Mol Sci. 2023 Dec 11;24(24):17363. doi: 10.3390/ijms242417363.
6
Differential effects of two phosphodiesterase 4 inhibitors against lipopolysaccharide-induced neuroinflammation in mice.两种磷酸二酯酶 4 抑制剂对脂多糖诱导的小鼠神经炎症的差异作用。
BMC Neurosci. 2023 Jul 31;24(1):39. doi: 10.1186/s12868-023-00810-7.
7
cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features.慢性阻塞性肺疾病中的环磷酸腺苷磷酸二酯酶信号传导:细胞、分子及临床特征综述
Biochem Biophys Rep. 2023 Feb 16;34:101438. doi: 10.1016/j.bbrep.2023.101438. eCollection 2023 Jul.
8
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.磷酸二酯酶4B抑制:一种治疗肺纤维化的潜在新策略。
Eur Respir Rev. 2023 Feb 21;32(167). doi: 10.1183/16000617.0206-2022. Print 2023 Mar 31.
9
Clinical Implication of Phosphodiesterase-4-Inhibition.磷酸二酯酶-4 抑制的临床意义。
Int J Mol Sci. 2022 Jan 21;23(3):1209. doi: 10.3390/ijms23031209.
10
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.吸入性磷酸二酯酶抑制剂治疗慢性阻塞性肺疾病。
Drugs. 2021 Nov;81(16):1821-1830. doi: 10.1007/s40265-021-01616-9. Epub 2021 Nov 3.